GlassScriptPhysician profile
Melissa Senf
NPI 1275170730
$768.82
in general payments reported to CMS, 2019-2025
14 companies · $408 in 2025
The $408 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $333 · 2023: $27.70 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $436.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $289.01 | 2021-2025 | Airsupra, Breztri, Farxiga |
| Biohaven Pharmaceuticals, INC. | $181.58 | 2021 | |
| Lilly USA, LLC | $70.95 | 2025 | Zepbound |
| Abbvie INC. | $41.48 | 2023-2025 | |
| Insulet Corporation | $34.24 | 2021 | |
| Stryker Corporation | $26.01 | 2025 | Clottriever Bold Catheter |
| Takeda Pharmaceuticals U.S.A., INC. | $25.55 | 2021 | |
| Novo Nordisk INC | $17.39 | 2025 | Ozempic |
| Eisai INC. | $17.01 | 2021 | |
| Pfizer INC. | $15.82 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.44 | 2021 | |
| Esperion Therapeutics, INC. | $14.08 | 2021 | |
| Merck Sharp & Dohme LLC | $12.01 | 2021 | |
| Forte Bio-Pharma LLC | $8.25 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Senf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.